BI 1810631
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 1810631, covering 2025-11-04 to 2025-11-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Healthy Men to Compare Two Different Oral Formulations of BI 1810631 and to Test How Food or Rabeprazole Influence the Amount of BI 1810631 in the Blood [Phase 1]